Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
Liu G, Oettel K, Ripple G, Staab MJ, Horvath D, Alberti D, Arzoomanian R, Marnocha R, Bruskewitz R, Mazess R, Bishop C, Bhattacharya A, Bailey H, Wilding G.
Liu G, et al.
Clin Cancer Res. 2002 Sep;8(9):2820-7.
Clin Cancer Res. 2002.
PMID: 12231522
Clinical Trial.